FierceBiotech 2026-02-02 Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health
FierceBiotech 2026-02-02 China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
FierceBiotech 2026-02-02 Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again
FierceBiotech 2026-02-02 Sanofi's troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease
FierceBiotech 2026-02-02 AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection
FierceBiotech 2026-01-30 Corcept submitted lead asset for approval despite FDA flagging risk of ‘significant review issues’
FierceBiotech 2026-01-30 Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech 2026-01-30 Chugai drops only AI-assisted antibody from pipeline but still holds high hopes for tech
FierceBiotech 2026-01-29 Formation Bio’s China shopping spree continues with $500M biobucks autoimmune pact
FierceBiotech 2026-01-29 Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales